NCT06428799 2026-03-18
EMBLEDDA-MMG
Carebot s.r.o.
Completed
Clinical Trials
1,537 trialsNCT06170619 2026-03-17
OCCLUDE
Boston Scientific Corporation
Completed
NCT06221397 2026-03-16
LEGIT_MC_EVCDA
AI Labs Group S.L
Completed
NCT05677308 2026-03-13
LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)
AstraZeneca
Completed
NCT06282991 2026-03-10
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Pfizer
Completed
NCT07215026 2026-03-10
UNCOVER
AstraZeneca
Completed
NCT04328662 2026-03-04
A Study of Ninlaro in Real World Clinical Practice in China
Takeda
Completed
NCT06137170 2026-03-02
RegoSeq
Bayer
Completed
NCT02184416 2026-02-27
ADONIS
Pfizer
Completed
NCT04498481 2026-02-27
TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.
Pfizer
Completed
NCT04894591 2026-02-27
SCLC
Jazz Pharmaceuticals
Completed
NCT05858749 2026-02-27
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer
Completed
NCT05968599 2026-02-25
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Pfizer
Completed
NCT07428941 2026-02-24
LegitHealth PH
AI Labs Group S.L
Completed
NCT07428954 2026-02-24
LegitHealthSAN
AI Labs Group S.L
Completed
NCT07429123 2026-02-24
Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers
AI Labs Group S.L
Completed
NCT05022342 2026-02-23
SPEAR
Novartis
Completed
NCT06676436 2026-02-18
REALNESS
AstraZeneca
Completed
NCT06565975 2026-02-12
RELION
Bristol-Myers Squibb
Completed
NCT05381753 2026-02-11
Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World
CStone Pharmaceuticals
Completed
NCT04721106 2026-02-10
Korea Post Marketing Surveillance (PMS) Study of Vizimpro
Pfizer
Completed
NCT06181734 2026-02-10
CONFIDHENCE
iOMEDICO AG
Completed
NCT02910557 2026-02-05
Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
Amgen
Completed
NCT06578351 2026-02-04
TRAM
Danone Asia Pacific Holdings Pte, Ltd.
Completed
NCT07374120 2026-02-02
Treatment Patterns and Key Endpoints Among Patients With Chronic-Phase Chronic Myeloid Leukemia in a Community Oncology Setting
Novartis
Completed
NCT05701007 2026-01-29
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Completed
NCT03516110 2026-01-23
PRISME
Ipsen
Completed
NCT07363434 2026-01-23
RESONATE
Novartis
Completed
NCT07213076 2026-01-21
Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.
AstraZeneca
Completed
NCT04889404 2026-01-14
LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
AstraZeneca
Completed
NCT05835778 2026-01-14
Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
AstraZeneca
Completed
NCT06163053 2026-01-14
A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home
Bristol-Myers Squibb
Completed
NCT07298252 2026-01-14
CARE-MMG-MRMC
Carebot s.r.o.
Completed
NCT04911998 2026-01-12
TavieSkin
Pierre Fabre Medicament
Completed
NCT06690489 2026-01-12
BCARE
Pierre Fabre Medicament
Completed
NCT06961331 2026-01-09
Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.
Pfizer
Completed
NCT07141563 2026-01-07
A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
Bristol-Myers Squibb
Completed
NCT05529979 2026-01-06
SaFE
Quantum Surgical
Completed
NCT04317599 2026-01-02
CAPSTAN CRC
Pierre Fabre Medicament
Completed
NCT04307134 2025-12-31
Besponsa Post Marketing Surveillance Study
Pfizer
Completed
NCT06072196 2025-12-31
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer
Completed
NCT04480814 2025-12-30
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
Pharmassist Ltd
Completed
NCT04490564 2025-12-30
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
Pharmassist Ltd
Completed
NCT04369053 2025-12-26
PREEMPT CRC
Freenome Holdings Inc.
Completed
NCT04998864 2025-12-23
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
Completed
NCT05844332 2025-12-22
LUTATHERA Injection General Use Result Survey
Novartis
Completed
NCT06055946 2025-12-22
BARVANA LONG
Aesculap AG
Completed
NCT04034095 2025-12-15
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
Janssen Pharmaceutical K.K.
Completed
NCT04961619 2025-12-12
LEAD Melanoma
Novartis
Completed
NCT04671615 2025-12-10
A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.
Pfizer
Completed